|
Market Closed -
22:55:02 20/08/2026 +03
|
5-day change
|
1st Jan Change
|
|
77.20 EUR
|
+0.52%
|
|
-2.53%
|
+35.39%
|
|
08-13 |
Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating
|
MT
| |
08-04 |
Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating
|
MT
| |
08-03 |
UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating
|
MT
| |
08-03 |
Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating
|
MT
| |
07-31 |
DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised
|
MT
| |
07-31 |
DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says
|
MT
| |
07-31 |
Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating
|
MT
| |
07-31 |
RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating
|
MT
| |
07-31 |
Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating
|
MT
| |
07-31 |
Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating
|
MT
| |
07-31 |
Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating
|
MT
| |
07-31 |
Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating
|
MT
| |
07-31 |
Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating
|
MT
| |
07-31 |
Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating
|
MT
| |
07-31 |
Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating
|
MT
| |
07-31 |
Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating
|
MT
| |
07-31 |
JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating
|
MT
| |
07-31 |
Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating
|
MT
| |
07-31 |
Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating
|
MT
| |
07-31 |
Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating
|
MT
| |
07-31 |
Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating
|
MT
| |
07-31 |
Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating
|
MT
| |
07-31 |
BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating
|
MT
| |
07-31 |
Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating
|
MT
| |
07-31 |
DexCom, Inc., Q2 2026 Earnings Call, Jul 30, 2026
| |
No results match your criteria Select your edition All financial news and data tailored to specific country editions |